162 related articles for article (PubMed ID: 19519959)
1. Capturing real-life patient care in psoriatic arthritis and its risks: the challenge of analysing registry data.
Aletaha D
Arthritis Res Ther; 2009; 11(3):112. PubMed ID: 19519959
[TBL] [Abstract][Full Text] [Related]
2. Outcomes research in psoriasis and psoriatic arthritis using large databases and research networks: a report from the GRAPPA 2013 Annual Meeting.
Armstrong AW; Gelfand JM; Garg A
J Rheumatol; 2014 Jun; 41(6):1233-6. PubMed ID: 24882860
[TBL] [Abstract][Full Text] [Related]
3. Evolution of psoriatic arthritis study patient population characteristics in the era of biological treatments.
Vandendorpe AS; de Vlam K; Lories R
RMD Open; 2019; 5(1):e000779. PubMed ID: 30740243
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Understanding the association between skin involvement and joint activity in patients with psoriatic arthritis: experience from the Corrona Registry.
Mease PJ; Etzel CJ; Huster WJ; Muram TM; Armstrong AW; Lisse JR; Rebello S; Dodge R; Murage MJ; Greenberg JD; Malatestinic WN
RMD Open; 2019; 5(1):e000867. PubMed ID: 31245045
[TBL] [Abstract][Full Text] [Related]
6. Clinical Characteristics, Disease Activity, and Patient-Reported Outcomes in Psoriatic Arthritis Patients With Dactylitis or Enthesitis: Results From the Corrona Psoriatic Arthritis/Spondyloarthritis Registry.
Mease PJ; Karki C; Palmer JB; Etzel CJ; Kavanaugh A; Ritchlin CT; Malley W; Herrera V; Tran M; Greenberg JD
Arthritis Care Res (Hoboken); 2017 Nov; 69(11):1692-1699. PubMed ID: 28376239
[TBL] [Abstract][Full Text] [Related]
7. Evidence-based Recommendations for the Management of Comorbidities in Rheumatoid Arthritis, Psoriasis, and Psoriatic Arthritis: Expert Opinion of the Canadian Dermatology-Rheumatology Comorbidity Initiative.
Roubille C; Richer V; Starnino T; McCourt C; McFarlane A; Fleming P; Siu S; Kraft J; Lynde C; Pope J; Gulliver W; Keeling S; Dutz J; Bessette L; Bissonnette R; Haraoui B
J Rheumatol; 2015 Oct; 42(10):1767-80. PubMed ID: 26178281
[TBL] [Abstract][Full Text] [Related]
8. Tumour necrosis factor inhibitors in the treatment of psoriatic arthritis: a view on effectiveness, clinical practice and toxicity.
Lories RJ; de Vlam K
Expert Opin Biol Ther; 2014 Dec; 14(12):1825-36. PubMed ID: 25366335
[TBL] [Abstract][Full Text] [Related]
9. Psoriatic Arthritis Registries.
Sarzi-Puttini P; Varisco V; Ditto MC; Benucci M; Atzeni F
J Rheumatol Suppl; 2015 Nov; 93():30-2. PubMed ID: 26523052
[TBL] [Abstract][Full Text] [Related]
10. Psoriatic arthritis.
Holdsworth J
Nurs Stand; 2003 Oct 15-21; 18(5):47-52; quiz 54-5. PubMed ID: 14603767
[TBL] [Abstract][Full Text] [Related]
11. Outcome measures in psoriatic arthritis clinical trials.
Reddy SM; Bingham III CO
Curr Rheumatol Rep; 2005 Aug; 7(4):299-305. PubMed ID: 16045833
[TBL] [Abstract][Full Text] [Related]
12. Peripartum issues in the inflammatory arthritis patient: A survey of the RAPPORT registry.
Dissanayake TD; Maksymowych WP; Keeling SO
Sci Rep; 2020 Feb; 10(1):3733. PubMed ID: 32111860
[TBL] [Abstract][Full Text] [Related]
13. Novel methods of measuring clinical outcomes from psoriasis and psoriatic arthritis clinical trials.
Villacorta R; Hay JW; Messali A
Expert Rev Pharmacoecon Outcomes Res; 2014 Aug; 14(4):545-58. PubMed ID: 24820676
[TBL] [Abstract][Full Text] [Related]
14. Quality of life and treatment satisfaction among patients with psoriasis and psoriatic arthritis and patients with psoriasis only : results of the 2005 Spring US National Psoriasis Foundation Survey.
Ciocon DH; Horn EJ; Kimball AB
Am J Clin Dermatol; 2008; 9(2):111-7. PubMed ID: 18284265
[TBL] [Abstract][Full Text] [Related]
15. Comorbidity in psoriatic arthritis and rheumatoid arthritis.
Sinnathurai P; Buchbinder R; Hill C; Lassere M; March L
Intern Med J; 2018 Nov; 48(11):1360-1368. PubMed ID: 30047189
[TBL] [Abstract][Full Text] [Related]
16. Psoriatic arthritis--what the dermatologist needs to know.
Laws P; Barton A; Warren RB
J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1270-7. PubMed ID: 20384693
[TBL] [Abstract][Full Text] [Related]
17. Psoriatic arthritis therapy advances.
Mease PJ
Curr Opin Rheumatol; 2005 Jul; 17(4):426-32. PubMed ID: 15956839
[TBL] [Abstract][Full Text] [Related]
18. Using epidemiological registry data to provide background rates as context for adverse events in a rheumatoid arthritis drug development program: a coordinated approach.
Nyberg F; Askling J; Berglind N; Franzén S; Ho M; Holmqvist M; Horne L; Lampl K; Michaud K; Pappas DA; Reed G; Symmons D; Tanaka E; Tran TN; Verstappen SM; Wesby-van Swaay E; Yamanaka H; Greenberg JD
Pharmacoepidemiol Drug Saf; 2015 Nov; 24(11):1121-32. PubMed ID: 26303866
[TBL] [Abstract][Full Text] [Related]
19. Limitations of clinical trials in chronic diseases: is the efficacy of methotrexate (MTX) underestimated in polyarticular psoriatic arthritis on the basis of limitations of clinical trials more than on limitations of MTX, as was seen in rheumatoid arthritis?
Pincus T; Bergman MJ; Yazici Y
Clin Exp Rheumatol; 2015; 33(5 Suppl 93):S82-93. PubMed ID: 26472658
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
